Spots Global Cancer Trial Database for A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Official Title: An Open-Label, Single Arm, Multicenter Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Study ID: NCT04321330
Conditions
Interventions
Study Description
Brief Summary: This is a phase II, open-label, single-arm, multicenter study of the efficacy and safety of atezolizumab treatment in participants with advanced thymic carcinoma who failed prior systemic therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sichuan Cancer Hospital, Chengdu City, , China
West China Hospital, Sichuan University; Department of Breast, Chengdu, , China
The Second Affiliated Hospital, Chongqing Medical University, Chongqing, , China
Fujian Medical University Union Hospital, Fuzhou City, , China
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, , China
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, , China
The affiliated hospital of Qingdao university, Qingdao City, , China
Shanghai Chest Hospital, Shanghai, , China
Shanghai Pulmonary Hospital, Shanghai, , China
Tianjin Cancer Hospital, Tianjin, , China
Henan Cancer Hospital, Zhengzhou, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
